Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-17

FDA Approved: LOJAIMIESS — Original Application (Xiromed LLC)

View source ↗

Summary

FDA approved LOJAIMIESS from Xiromed LLC as an original application for a combined levonorgestrel and ethinyl estradiol contraceptive tablet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOJAIMIESS (LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS)

Snippet

ORIG AP for LOJAIMIESS (LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL TABLETS)